| Original language | English |
|---|---|
| Pages (from-to) | 787-789 |
| Number of pages | 3 |
| Journal | British Journal of Dermatology |
| Volume | 179 |
| Issue number | 3 |
| DOIs | |
| Publication status | Published - Sep 1 2018 |
ASJC Scopus subject areas
- Dermatology
Cite this
MiR-146a-5p correlates with clinical efficacy in patients with psoriasis treated with the tumour necrosis factor-alpha inhibitor adalimumab. / Mensà, E.; Recchioni, R.; Marcheselli, F.; Giuliodori, K.; Consales, V.; Molinelli, E.; Prattichizzo, F.; Rippo, M. R.; Campanati, A.; Procopio, A. D.; Olivieri, F.; Offidani, A. M.
In: British Journal of Dermatology, Vol. 179, No. 3, 01.09.2018, p. 787-789.Research output: Contribution to journal › Letter
}
TY - JOUR
T1 - MiR-146a-5p correlates with clinical efficacy in patients with psoriasis treated with the tumour necrosis factor-alpha inhibitor adalimumab
AU - Mensà, E.
AU - Recchioni, R.
AU - Marcheselli, F.
AU - Giuliodori, K.
AU - Consales, V.
AU - Molinelli, E.
AU - Prattichizzo, F.
AU - Rippo, M. R.
AU - Campanati, A.
AU - Procopio, A. D.
AU - Olivieri, F.
AU - Offidani, A. M.
PY - 2018/9/1
Y1 - 2018/9/1
UR - http://www.scopus.com/inward/record.url?scp=85052700855&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85052700855&partnerID=8YFLogxK
U2 - 10.1111/bjd.16659
DO - 10.1111/bjd.16659
M3 - Letter
AN - SCOPUS:85052700855
VL - 179
SP - 787
EP - 789
JO - British Journal of Dermatology
JF - British Journal of Dermatology
SN - 0007-0963
IS - 3
ER -